Psyence Biomedical Ltd.
PBM
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.25M
Close$
$9.48
124.6% upside
Current Fair Value
124.6% upsideUndervalued by 124.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.25 Million |
|---|---|
| Enterprise Value | $-945,132.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-12.56 |
| Beta | 1.69 |
| Outstanding Shares | 1,481,527 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.4 |
|---|---|
| PEG | 0.06 |
| Price to Sales | - |
| Price to Book Ratio | 0.53 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 28, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 24.88%▲ 14.67% |
|---|---|
| Total Invested | $1.24M▲ 115.66% |
| Investors Holding | 9▲ 7.00% |
ESG Score
No data